The Graduate School of Medicine, The University of Tokyo, Department of Human Pathology and Diagnostic Pathology (hereinafter, The University of Tokyo) and NTT East Corporation (hereinafter, NTT East) will begin verification in late July 2026 for a data storage infrastructure that enables safe and efficient long-term storage and utilization of large-capacity medical and research data, such as digital pathology images. This initiative will leverage storage technology provided by International Business Machines Corporation (IBM) and is a new development within the "Remote Bio DX Project*1" that has been underway since 2023. Through the "Remote Bio DX Project," The University of Tokyo and NTT East have previously verified aspects such as "remote operation of optical microscopes*2" in the fields of clinical pathology, academia, and drug discovery, focusing on operability and usability, and have confirmed the feasibility and utility for their application. This verification will aim to realize a highly reliable data storage infrastructure that safely and long-term stores large-capacity medical and research data, supporting future AI analysis, re-analysis, and research use. This will be achieved by combining The University of Tokyo's expertise in pathology and actual data such as pathology images, secure access via NTT East's closed network, and IBM's ultra-high-density tape storage, "IBM Storage Deep Archive*3." *1: NTT East University of Tokyo Lab "Remote Bio DX Project" Introduction Page https://nt-lab.adm.u-tokyo.ac.jp/remote-bioDX/ *2: Industry-Academia Collaboration Succeeds in Realizing Remote Use of Optical Microscopes to Support Research and Clinical Ecosystems https://www.ntt-east.co.jp/release/detail/20260325_01.html *3: IBM Storage Deep Archive Ultra-high-density tape storage with an S3 Glacier API-compatible interface. Background and Objectives of This Initiative With the advancement of generative AI and the evolution of a data-driven society, the need to safe